Key Market Indicators
Sales of digestive system disorder medicines in Italy are set to reach $3.3 billion by 2026. This is a 0.2% growth year on year since 2021, when the market was valued at $3.3 billion. Since 2016, the Italian market has grown by 1.9% year on year. In 2021, Italy was the sixth largest market in the world for digestive system disorder medicines, behind Spain ($3.3 billion), Japan ($3.2 billion), South Korea ($2.8 billion), and Canada ($2.1 billion).